Press Release 03 July 2025 White & Case advises Adelis on sale of majority stake in Europa Biosite to EQT Healthcare Growth
Press Release 02 July 2025 White & Case advises Neopharmed Gentili on acquisition of ORLADEYO®’s European business from BioCryst Pharmaceuticals
Press Release 03 March 2025 White & Case advises Helix Acquisition Corp. II on its US$949 million business combination with BridgeBio Oncology Therapeutics
